BIOCHEMISTRY OF ALZHEIMER’S DISEASE

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 2

Abstract

Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs).[1] Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Furthermore, the degree of dementia is clearly associated more with the degree of neurofibrillary pathology than with the amyloid plaque burden. In general, amyloid formation may very well be at the end of a pathophysiological cascade, set in motion by many different triggers. This cascade could involve excessive apoptosis, followed by necrosis and inflammation.[2] The pathogenesis of AD is complicated, but further identification of the processes of neurodegeneration will also lead to identification of the factors that make specific neurons vulnerable and, hopefully, point the way to a means to prevent neuronal degeneration at an early stage.

Authors and Affiliations

Dr. Anil Batta

Keywords

Related Articles

A REVIEW ON DUTIES AND LAWS RELATED TO MEDICAL PRACTITIONERS IN MEDICOLEGAL ASPECTS OF POISONING

Every poisoning case, whether acute or chronic, has medicolegal overtones. Basically there are three categories of medicolegal cases: accidental, suicidal, and homicidal. The majority constitutes either accidental or sui...

ROLE OF LONG NON-CODING RNA CDKN2B-AS1 AND HOMOCYSTEINE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY

Background: Ischemic cardiomyopathy (ICM) refers to significantly impaired function of left ventricle that is caused by coronary artery disease. The aim of this study is to assess the levels of lnc-RNA-CDKN2B-AS1 and hom...

A CRITICAL REVIEW ON BREWING OF BEER

Human and yeast have very old relationship for the production of various beverages and food products through fermentation. Several discoveries have created better technologies and abilities for improved fermentation on a...

BREAST CANCER IN MEN ABOUT NINE CASES MANAGED AT THE MOHAMED VI CENTER FOR ONCOGYNECOLOGY

Breast cancer in men is a rare disease. Risk factors are many and varied. The diagnosis is made at a later age than in women and at a later stage. The clinical presentation of the disease differs a little in men. All his...

ORGANOLEPTIC CHARACTERS, PHYSIOCHEMICAL AND PRELIMINARY PHYTOCHEMICAL ANALYSIS OF THRIKADUGU, PARANGIPATTAI AND MASIKKAI CHOORANAM

AIM: The aim of the study is to evaluate Organoleptic characters, Physiochemical parameters and to screen the phytochemicals present in three Siddha formulations – Thrikaduku chooranam (TKC), Parangipattai chooranam (PPC...

Download PDF file
  • EP ID EP650861
  • DOI -
  • Views 151
  • Downloads 0

How To Cite

Dr. Anil Batta (2018). BIOCHEMISTRY OF ALZHEIMER’S DISEASE. World Journal of Pharmaceutical and life sciences, 4(2), 68-72. https://europub.co.uk/articles/-A-650861